Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human SLC2A1 Polyclonal Antibody

Catalog #:   PHC85901 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P11166
Overview

Catalog No.

PHC85901

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human SLC2A1.

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Solute carrier family 2, facilitated glucose transporter member 1, Glucose transporter type 1, erythrocyte/brain, GLUT-1, HepG2 glucose transporter, SLC2A1, GLUT1

Purification

Purified by antigen affinity column.

Accession

P11166

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with SLC2A1 antibody (PHC85901) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 32 kDa
    Observed MW: 32 kDa
References

Glucose transporter-1 (GLUT-1) upregulation in vitiligo: A possible link to skin depigmentation., PMID:40032057

Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer., PMID:40004024

The novel HSP90 monoclonal antibody 9B8 ameliorates articular cartilage degeneration by inhibiting glycolysis via the HIF-1 signaling pathway., PMID:39229534

Upregulation of Transferrin Receptor 1 (TfR1) but Not Glucose Transporter 1 (GLUT1) or CD98hc at the Blood-Brain Barrier in Response to Valproic Acid., PMID:39056763

Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation., PMID:38899504

Ze-Qi-Tang formula inhibits MDSCs glycolysis through the down-regulation of p21/Hif1α/Glut1 signal in psoriatic-like mice., PMID:38810554

Mast Cells are Dependent on Glucose Transporter 1 (GLUT1) and GLUT3 for IgE-mediated Activation., PMID:38565760

GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma., PMID:38394402

GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity., PMID:38340319

Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis., PMID:37530530

Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma., PMID:37433700

Ehrlichia Wnt short linear motif ligand mimetic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis., PMID:36945589

Clinical application of trio-based whole-exome sequencing in idiopathic generalized epilepsy., PMID:36842888

Establishment of a flow cytometry screening method for patients with glucose transporter 1 deficiency syndrome., PMID:36618999

GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues., PMID:35311938

TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A., PMID:34588517

Relocation of phosphofructokinases within epithelial cells is a novel event preceding breast cancer recurrence that accurately predicts patient outcomes., PMID:34348486

Cancer-Associated Fibroblasts Regulate Bladder Cancer Invasion and Metabolic Phenotypes through Autophagy., PMID:34122670

PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis., PMID:33531346

Oral glucose tolerance test does not affect degree of hemoglobin glycation as measured by routine assay., PMID:33278381

Reprogramming of synovial macrophage metabolism by synovial fibroblasts under inflammatory conditions., PMID:33256735

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival., PMID:32967636

Senescence and autophagy in usual interstitial pneumonia of different etiology., PMID:32851507

Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human., PMID:32698806

Activation of AMPK pathway compromises Rab11 downregulation-mediated inhibition of Schwann cell proliferation in a Glut1 and Glut3-dependent manner., PMID:31954765

Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy., PMID:31907603

Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma., PMID:31832727

Emerging views of mitophagy in immunity and autoimmune diseases., PMID:30951392

[18 F]-Fluorodeoxy-D-glucose uptake in prurigo nodules induced by the membranous expression of glucose transporter., PMID:30816575

Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome., PMID:30582284

Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release., PMID:30464343

Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma., PMID:30422215

Immunohistochemical Expression of Melatonin Receptor MT1 and Glucose Transporter GLUT1 in Human Breast Cancer., PMID:30360728

Glucose transporter-1 (GLUT-1) expression in psoriasis: correlation with disease severity., PMID:29797802

Deletion of GLUT1 in mouse lens epithelium leads to cataract formation., PMID:29604281

[Value of immunocytochemistry in differential diagnosis of gastric adenocarcinoma, reactive mesothelial cells and malignant epithelial mesothelioma in metastatic effusion fluid]., PMID:29534357

Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells., PMID:29301589

The Complex Structure of the Mouse Placental Labyrinth Revealed by Double Immunofluorescence Labeling of Slc2a1 and Gjb2., PMID:28724843

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer., PMID:28542798

Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments., PMID:28498467

A distinct functional distribution of α and γ motoneurons in the rat trigeminal motor nucleus., PMID:28326439

Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters., PMID:28281552

Multivacuolated mucin-filled cells: a unique cell characteristic of plexiform neurofibroma. A report of 11 cases., PMID:27816720

[Value of the expression of Ki-67 and membrane protein glucose transporter GLUT1 in the diagnosis of neoplastic transformation of the oral mucosal epithelium]., PMID:27804941

The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients., PMID:27666620

Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models., PMID:27569031

miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1., PMID:27476171

GLUT1 activity contributes to the impairment of PEDF secretion by the RPE., PMID:27440994

Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions., PMID:27272799

Upregulated Glucose Metabolism Correlates Inversely with CD8+ T-cell Infiltration and Survival in Squamous Cell Carcinoma., PMID:27206847

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human SLC2A1 Polyclonal Antibody [PHC85901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only